Document is current
Any future updates will be listed below
-
Authors
Xiang, Yajie
Du, Xiaoyan
Yang, Hongmei
Wang, Peng
Yin, Bangmin
Wang, Zhengyang
Wang, Haiyang
Liu, Lanxiang
Zhang, Hanping
Ren, Yikun
Chen, Xiangyu
Ren, Yi
Li, Wei
Xie, Peng https://orcid.org/0000-0002-0081-6048
- License Information
-
More Information
Article History
Received: 9 September 2025
Revised: 5 December 2025
Accepted: 5 January 2026
First Online: 30 January 2026
Competing interests
: PX reported receiving lecture fees from Eli Lilly and Company, Janssen Pharmaceutica, Lundbeck and Pfizer, Inc. Other authors declare no competing interests.
